These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 20683976)
1. Targeting heme oxygenase/adiponectin axis for chronic hepatitis C treatment. Salamone F; Li Volti G Hepatology; 2010 Aug; 52(2):801. PubMed ID: 20683976 [No Abstract] [Full Text] [Related]
2. Genetic variations in heme oxygenase-1 and chronic hepatitis. Bonkovsky HL; Lambrecht RW; Naishadham D Hepatology; 2010 Jul; 52(1):400-1. PubMed ID: 20232486 [No Abstract] [Full Text] [Related]
3. Beyond hepatitis C: The anti-inflammatory role of heme oxygenase-1 in systemic infections. Kapoor S Hepatology; 2009 Mar; 49(3):1052; author reply 1052. PubMed ID: 19241484 [No Abstract] [Full Text] [Related]
4. The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. Lehmann E; El-Tantawy WH; Ocker M; Bartenschlager R; Lohmann V; Hashemolhosseini S; Tiegs G; Sass G Hepatology; 2010 Feb; 51(2):398-404. PubMed ID: 20044809 [TBL] [Abstract][Full Text] [Related]
5. Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy. Lu JY; Chuang LM; Yang WS; Tai TY; Lai MY; Chen PJ; Kao JH; Lee CZ; Lee HS Liver Int; 2005 Aug; 25(4):752-9. PubMed ID: 15998426 [TBL] [Abstract][Full Text] [Related]
6. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C. Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648 [TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase/Akt pathway mediates heme oxygenase-1 regulation by lipopolysaccharide. Pischke SE; Zhou Z; Song R; Ning W; Alam J; Ryter SW; Choi AM Cell Mol Biol (Noisy-le-grand); 2005 Oct; 51(5):461-70. PubMed ID: 16309568 [TBL] [Abstract][Full Text] [Related]
8. [Interferons and chronic hepatitis C treatment]. Cai DC; Ren H Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):847-8. PubMed ID: 18073070 [No Abstract] [Full Text] [Related]
15. Heme oxygenase-1 expression in disease states. Deshane J; Wright M; Agarwal A Acta Biochim Pol; 2005; 52(2):273-84. PubMed ID: 15933765 [TBL] [Abstract][Full Text] [Related]
16. [Heme oxygenase-1 and oxidative stress]. Xu XZ; He P Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):706-9. PubMed ID: 19695210 [No Abstract] [Full Text] [Related]
17. Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells. Kim DH; Burgess AP; Li M; Tsenovoy PL; Addabbo F; McClung JA; Puri N; Abraham NG J Pharmacol Exp Ther; 2008 Jun; 325(3):833-40. PubMed ID: 18334666 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of heme oxygenase-1-mediated cardiac and pulmonary vascular protection in chronic hypoxia: roles of carbon monoxide and bilirubin. Vitali SH; Mitsialis SA; Christou H; Fernandez-Gonzalez A; Liu X; Kourembanas S Chest; 2005 Dec; 128(6 Suppl):578S-579S. PubMed ID: 16373841 [No Abstract] [Full Text] [Related]
19. The evolving role of leptin and adiponectin in chronic liver diseases. Tsochatzis E; Papatheodoridis GV; Archimandritis AJ Am J Gastroenterol; 2006 Nov; 101(11):2629-40. PubMed ID: 16952281 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of cell protection by heme oxygenase-1. Gozzelino R; Jeney V; Soares MP Annu Rev Pharmacol Toxicol; 2010; 50():323-54. PubMed ID: 20055707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]